Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-001384
Filing Date
2020-02-13
Accepted
2020-02-13 16:06:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 36706
2 filename2.txt TEXT-EXTRACT 7260
  Complete submission text file 0000000000-20-001384.txt   58532
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filed for) CIK: 0001664710 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations